Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia
about
Early planned removal of umbilical venous catheters to prevent infection in newborn infantsOverview of ventilation strategies for the early management of intubated preterm infantsParacetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infantsPentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsMesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infantsParacetamol (acetaminophen) for patent ductus arteriosus in preterm and/or low-birth-weight infantsSystemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infantsPentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsCaffeine therapy in preterm infantsAffect of Early Life Oxygen Exposure on Proper Lung Development and Response to Respiratory Viral InfectionsPredictors of bronchopulmonary dysplasiaFrontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasiaDefining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung DiseaseSphingolipids as cell fate regulators in lung development and diseaseUnderstanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary DysplasiaSuppression of inflammatory cell trafficking and alveolar simplification by the heme oxygenase-1 product carbon monoxideUtilization of inhaled corticosteroids for infants with bronchopulmonary dysplasiaSystemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus.Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.Differences in Eccentricity Index and Systolic-Diastolic Ratio in Extremely Low-Birth-Weight Infants with Bronchopulmonary Dysplasia at Risk of Pulmonary Hypertension.Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).Mechanisms of cough provocation and cough resolution in neonates with bronchopulmonary dysplasia.Heart rate characteristics and neurodevelopmental outcome in very low birth weight infants.Clinical and laboratory factors that predict death in very low birth weight infants presenting with late-onset sepsis.Growth of very low birth weight infants fed with milk from a human milk bank selected according to the caloric and protein value.Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.The ELGAN study of the brain and related disorders in extremely low gestational age newborns.Long-term effects of recurrent intermittent hypoxia and hyperoxia on respiratory system mechanics in neonatal mice.Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study.DoMINO: Donor milk for improved neurodevelopmental outcomes.Inhaled nitric oxide decreases leukocyte trafficking in the neonatal mouse lung during exposure to >95% oxygenNeonatal respiratory morbidity following exposure to chorioamnionitis.Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia.Early blood gas predictors of bronchopulmonary dysplasia in extremely low gestational age newborns.Secondhand smoke exposure in preterm infants with bronchopulmonary dysplasiaChronic lung disease in the preterm infant. Lessons learned from animal modelsThe impact of bronchopulmonary dysplasia on caregiver health related quality of life during the first 2 years of lifeRespiratory outcomes of children with BPD and gastrostomy tubes during the first 2 years of life.The effects of designation and volume of neonatal care on mortality and morbidity outcomes of very preterm infants in England: retrospective population-based cohort study.
P2860
Q24185956-D84A5894-CD69-4504-B3DB-7CC9DCCE3E58Q24186988-6B693109-D7F1-4550-A1E4-0131A745954BQ24187317-390A8AFE-BC14-49DF-B539-AA7397F5852AQ24187852-DDEB22DA-AE65-4EFE-B11A-B33234C9013CQ24188275-5B70FEB2-1E11-492C-9386-D8F212AB51FFQ24201052-D25A30C1-A16F-4C8F-B471-8D61B6FE5E14Q24201323-FDDD44F7-3C64-478E-9D6D-10A683987417Q24201869-D372F2F6-76CF-4AE1-BABF-9951CD80E45CQ26777204-83200B8F-0F9A-4F2A-A26E-A7015E1D0AC7Q26795723-8C34040E-1CE7-475F-BA1D-D1D9024A07CCQ26829843-07CE500B-6339-403C-8C9C-40C7C2BFB45CQ27025986-509DE109-8FDC-4074-B200-DE8A938B84EAQ28067464-58D35286-141B-4D7D-9CA0-94F8B30463C0Q28084945-74BE273B-735D-41A3-BD1B-845F12EADB11Q28087007-36524313-A893-40BE-8A59-57F0336B0FA7Q28384205-81D65E5D-968F-4D42-AE71-6229ECB02D1EQ28542831-F59F0A08-8E88-42D1-9E1D-3B7AA152F593Q30238696-DC1BCD78-F5F5-44B4-9AD0-AA1F7E95A5B6Q30241040-9375E662-269F-4543-9040-B589253E171AQ30301367-1757DC88-1C67-4C5A-817F-C46E55E01776Q30362930-CBE708D4-60B8-40F6-9C9C-B53D7D7B9A13Q30371667-4E1AC6F6-4F68-4A22-BDB7-BAFED6BB5FF4Q30373399-FCD9FF8E-8DF5-40FD-9AE5-1A1152EDA25FQ30436651-E32996C5-AE09-43E7-B5F6-B828C7BE5157Q33412631-24A3045D-60B9-4F0F-A10A-82C14E049861Q33452932-0630A6FB-082D-4046-AC26-5FA15C05FA4DQ33561756-F24D955E-3D32-4912-B989-9DE31E83BE75Q33570970-FF15FDA8-33F1-48BA-8CF0-C18F62F51F99Q33574892-82ED0D0A-945E-4EA2-8FD4-FB70D802B0E9Q33603998-50F9D875-12E0-4687-BC03-9E4132DBC4C3Q33655438-D07145DD-5F3C-48C4-9F59-6C3C71FD8F16Q33693056-9FAE8A70-FF4D-43DB-8A13-8813AEBEA656Q33702849-B13A3128-C0FB-44F6-8559-3DA0CAA49E5BQ33710305-39CB831E-C49F-44B7-9513-ADFFA1CEC222Q33735779-2C2C8F0A-D6EE-462C-B4C7-8B4AB9BA8A39Q33737104-7F6C1883-C6DF-414F-9F28-32B3A17B3820Q33756577-04A2BE7F-C95C-49F7-863E-74D16B74EFBFQ33869615-E6E4ACD8-B3A7-4DFD-A23F-A00D0F294404Q33869670-6B7AD360-596A-4225-A999-12BB1D5DCBCEQ33879602-8029F0BD-3508-4BDA-B132-A20980CDB359
P2860
Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Validation of the National Ins ...... of bronchopulmonary dysplasia
@ast
Validation of the National Ins ...... of bronchopulmonary dysplasia
@en
Validation of the National Ins ...... of bronchopulmonary dysplasia
@nl
type
label
Validation of the National Ins ...... of bronchopulmonary dysplasia
@ast
Validation of the National Ins ...... of bronchopulmonary dysplasia
@en
Validation of the National Ins ...... of bronchopulmonary dysplasia
@nl
prefLabel
Validation of the National Ins ...... of bronchopulmonary dysplasia
@ast
Validation of the National Ins ...... of bronchopulmonary dysplasia
@en
Validation of the National Ins ...... of bronchopulmonary dysplasia
@nl
P2093
P3181
P356
P1433
P1476
Validation of the National Ins ...... of bronchopulmonary dysplasia
@en
P2093
Alan H Jobe
Avroy A Fanaroff
Betty R Vohr
Kenneth Poole
Linda L Wright
Lisa A Wrage
Michele C Walsh
Richard A Ehrenkranz
P304
P3181
P356
10.1542/PEDS.2005-0249
P407
P577
2005-12-01T00:00:00Z